Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients.

Meyer A, Troyanov Y, Drouin J, Oligny-Longpré G, Landon-Cardinal O, Hoa S, Hervier B, Bourré-Tessier J, Mansour AM, Hussein S, Morin V, Rich E, Goulet JR, Chartrand S, Hudson M, Nehme J, Makhzoum JP, Zarka F, Villeneuve E, Raynauld JP, Landry M, O'Ferrall EK, Ferreira J, Ellezam B, Karamchandani J, Larue S, Massie R, Isabelle C, Deschênes I, Leclair V, Couture H, Targoff IN, Fritzler MJ, Senécal JL.

Arthritis Res Ther. 2020 Jan 8;22(1):5. doi: 10.1186/s13075-019-2093-6.

2.

Letter in response to 'Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors'.

Leclair V, Landon-Cardinal O, Hudson M.

Eur J Cancer. 2019 May;112:47-48. doi: 10.1016/j.ejca.2019.02.010. Epub 2019 Mar 23. No abstract available.

PMID:
30913530
3.

Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study.

Leclair V, Svensson J, Lundberg IE, Holmqvist M.

J Rheumatol. 2019 Nov;46(11):1509-1514. doi: 10.3899/jrheum.181248. Epub 2019 Mar 15.

PMID:
30877220
4.

Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study.

Leclair V, Galindo-Feria AS, Dastmalchi M, Holmqvist M, Lundberg IE.

Rheumatology (Oxford). 2019 Jul 1;58(7):1214-1220. doi: 10.1093/rheumatology/key450.

PMID:
30690633
5.

Response to: 'Time to personalise the treatment of anti-MDA-5 associated lung disease' by Lake et al.

Leclair V, Lundberg IE, Tjärnlund A.

Ann Rheum Dis. 2019 Jun;78(6):e53. doi: 10.1136/annrheumdis-2018-213519. Epub 2018 May 3. No abstract available.

PMID:
29724727
6.

Successful Lung Transplantation in a Case of Rapidly Progressive Interstitial Lung Disease Associated with Antimelanoma Differentiation-associated Gene 5 Antibodies.

Leclair V, Labirua-Iturburu A, Lundberg IE.

J Rheumatol. 2018 Apr;45(4):581-583. doi: 10.3899/jrheum.171047. No abstract available.

PMID:
29606647
7.

New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.

Leclair V, Lundberg IE.

Curr Rheumatol Rep. 2018 Mar 17;20(4):18. doi: 10.1007/s11926-018-0726-4. Review.

8.

Recent clinical trials in idiopathic inflammatory myopathies.

Leclair V, Lundberg IE.

Curr Opin Rheumatol. 2017 Nov;29(6):652-659. doi: 10.1097/BOR.0000000000000430. Review.

PMID:
28763333
9.

Cutaneous Lymphangiectasia in Systemic Sclerosis.

Hoa S, Leclair V, Hudson M.

Arthritis Rheumatol. 2017 Feb;69(2):446. doi: 10.1002/art.40000. No abstract available.

10.

Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review.

Leclair V, Regardt M, Wojcik S, Hudson M; Canadian Inflammatory Myopathy Study (CIMS).

PLoS One. 2016 Aug 9;11(8):e0160753. doi: 10.1371/journal.pone.0160753. eCollection 2016. Review.

11.

EPA pilot program would allow states to use confidential data in risk assessments.

Leclair V.

Environ Sci Technol. 1997 Aug;31(8):356A. doi: 10.1021/es972412m. No abstract available.

PMID:
21650440
12.

California considers tougher diesel exhaust rule.

Leclair V.

Environ Sci Technol. 1997 Aug;31(8):355A. doi: 10.1021/es972411u. No abstract available.

PMID:
21650438
13.

States pushing for greater regulatory flexibility from EPA.

Leclair V.

Environ Sci Technol. 1997 Aug;31(8):354A. doi: 10.1021/es9724093. No abstract available.

PMID:
21650436
14.

OTAG recommends ozone controls tailored to pollution transport.

Leclair V.

Environ Sci Technol. 1997 Aug;31(8):352A-3A. doi: 10.1021/es972406q. No abstract available.

PMID:
21650433
15.

G7 nations to focus on children's health.

Leclair V.

Environ Sci Technol. 1997 Jul;31(7):313A. doi: 10.1021/es972362l. No abstract available.

PMID:
21650737
16.

U.S. toxic wastes increase, prompting push for chemical use reporting.

Leclair V.

Environ Sci Technol. 1997 Jul;31(7):311A. doi: 10.1021/es9723592. No abstract available.

PMID:
21650734
17.

EPA proposes a national low-emission vehicle program.

Leclair V.

Environ Sci Technol. 1997 Jul;31(7):310A-1A. doi: 10.1021/es972357h. No abstract available.

PMID:
21650733
18.

EPA toxics office to create "safe haven" for science policy, risk work.

Leclair V.

Environ Sci Technol. 1997 Jun;31(6):271A. doi: 10.1021/es972312g. No abstract available.

PMID:
21650269
19.

Federal agencies battle over risks from low-level radiation exposure.

Leclair V.

Environ Sci Technol. 1997 Jun;31(6):268A. doi: 10.1021/es972307c. No abstract available.

PMID:
21650264
20.

Toxics Release Inventory expanded to cover seven new industries.

Leclair V.

Environ Sci Technol. 1997 Jun;31(6):267A. doi: 10.1021/es972305s. No abstract available.

PMID:
21650262
21.

"Streamlined" water-testing plan frees lab to fine-tune methods.

Leclair V.

Environ Sci Technol. 1997 Jun;31(6):266A-7A. doi: 10.1021/es9723040. No abstract available.

PMID:
21650261
22.

Genetically engineered microbes notification required.

Leclair V.

Environ Sci Technol. 1997 May;31(5):223A. doi: 10.1021/es972267c. No abstract available.

PMID:
21650566
23.

"Common Sense" reform initiatives falters.

Leclair V.

Environ Sci Technol. 1997 May;31(5):222A-3A. doi: 10.1021/es972265s. No abstract available.

PMID:
21650564
24.

Chemical industry groups pledge $8 million for endocrine research.

Leclair V.

Environ Sci Technol. 1997 May;31(5):221A. doi: 10.1021/es9722638. No abstract available.

PMID:
21650563
25.

Contaminated sediment management needs better assessment tools, NRC says.

Leclair V.

Environ Sci Technol. 1997 May;31(5):220A. doi: 10.1021/es972261n. No abstract available.

PMID:
21650560
26.

Technology Update: Lasers could eliminate precision cleaning solvents.

Leclair V.

Environ Sci Technol. 1997 May;31(5):215A. doi: 10.1021/es9722537. No abstract available.

PMID:
21650552
27.

Smaller SITE program changes direction.

Leclair V.

Environ Sci Technol. 1997 Apr;31(4):178A. doi: 10.1021/es972216f. No abstract available.

PMID:
21650614
28.

Courts push states, EPA to create TMDL water programs.

Leclair V.

Environ Sci Technol. 1997 Apr;31(4):178A-9A. doi: 10.1021/es972215n. No abstract available.

PMID:
21650613
29.

MTBE water contamination raises health concerns, research questions.

Leclair V.

Environ Sci Technol. 1997 Apr;31(4):176A-7A. doi: 10.1021/es9722133. No abstract available.

PMID:
21650611
30.

Particulates, ozone standards due July 19.

Leclair V.

Environ Sci Technol. 1997 Apr;31(4):175A. doi: 10.1021/es972212a. No abstract available.

PMID:
21650610
31.

States, EPA push to share confidential industry-provided toxic chemical data.

Leclair V.

Environ Sci Technol. 1997 Mar;31(3):128A. doi: 10.1021/es972170q. No abstract available.

PMID:
21663091
32.

Transportation planners lack clean air tools, NRC says.

Leclair V.

Environ Sci Technol. 1997 Mar;31(3):127A. doi: 10.1021/es972169r. No abstract available.

PMID:
21663089

Supplemental Content

Loading ...
Support Center